Search earnings tickers

VRTX

2025Q1AMC

Vertex Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2025-05-05 · Fiscal end 2025-03-31 · Features as of 2025-05-05

← Earnings history

Street

Consensus EPS4.29

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.3%

IV front—

P/C full—

P/C front—

Features as of2025-05-05

Run-up

Close—

Ret 5d+0.7%

Ret 10d+4.7%

Ret 20d+5.4%

Ret 30d-0.6%

Print

Actual EPS

4.06Miss

Estimated EPS4.29

Actual revenue

2.8B

Surprise %-5.4%

Beat / missMiss

Beat streak 40

Beat streak 80

Reaction

1-day stock reaction-3.3%

Implied vs actual

Implied 2.3%Actual 6.9%

Gap reaction-6.9%

Day result-10.0%

Next-day upNo

Realized / IV3.05×

Post tape

Post 5d-4.0%

Post 10d-0.6%

Post volume8.0M

Vol ×10d5.60×

Vol ×20d4.91×

Post range8.4%